drugset / Trial / NCT03715699
Leflunomide Treatment for IgG4-RD
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is an open-label randomized controlled trial aiming to investigate whether the efficacy and side effect of Leflunpomide plus glucocorticoid.
Timeline
- Start
- 2018-07-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leflunomide | Small molecule | 10 mg | — |
| Background | Prednisone | Other / unclassified | 7.5 mg | — |
| Background | Prednisone | Other / unclassified | 10 mg | — |